FDA Guidance for Industry: Residual Drug in Transdermal and Related Delivery Systems
Titel:
FDA Guidance for Industry: Residual Drug in Transdermal and Related Delivery Systems
Internet:
Herkunft/Verlag:
FDA, http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM220796.pdf
Inhalt:
Empfehlungen an Entwickler und Hersteller von Transdermalen Systemen und ähnliches